Evolution News and Research

RSS

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.

5 Dec 2013

Professor receives Research Fellowship to complete biography on nutrition and heart disease researcher

A University of Oklahoma associate professor has received a National Endowment for the Humanities Research Fellowship to complete a biography on nutrition and heart disease researcher Ancel Keys (1904-2004).

5 Dec 2013

UCLA researchers discover how prostate cancer stem cells evolve as the disease grows

UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.

4 Dec 2013

AAAS Honors Two Tufts University faculty members as Fellows

Two faculty members at Tufts University have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon AAAS members by their peers. John M. Coffin and planetary scientist Samuel P. Kounaves are among 388 new Fellows recognized by AAAS based on their distinguished efforts to advance science or its applications.

4 Dec 2013

Better understanding of cancer evolution could help in early detection of cancers

A new appreciation of how cancer cells evolve could help scientists design better screening methods to catch cancer before it advances.

4 Dec 2013

MHIF creates scientific program to address gaps in treating valvular heart disease patients

Despite significant medical advances, there continue to be significant gaps in the health care of the growing number of patients with valvular heart disease. In the USA, the total number of people aged 65 years or older with valvular heart disease will grow to approximately 5.2 million by year 2020, and 6.8 million individuals by the year 2030. The Minneapolis Heart Institute Foundation- has created a scientific program, "Valve Summit 2014: The Science and Delivery of Optimal, Multi-Disciplinary Care," to address the ongoing, complex evolution in the clinical management of patients with valvular heart disease. The conference will be held on April 25th and 26th at the Radisson Blu in downtown Minneapolis.

4 Dec 2013

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

Using quantitative models of bacterial growth, a team of UC San Diego biophysicists has discovered the bizarre way by which antibiotic resistance allows bacteria to multiply in the presence of antibiotics, a growing health problem in hospitals and nursing homes across the United States.

30 Nov 2013

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Miren Apilánez, researcher in the Department of Paediatrics of the UPV/EHU-University of the Basque Country, has studied the evolution that took place between 1984 and 2011 in paediatric HIV infection in Gipuzkoa. The development of methods to diagnose the disease coupled with increasingly more effective treatments have made it possible to reduce mother-to-child transmission (vertical transmission) from 23.9% to 2.4%, thus virtually eradicating infection in children.

30 Nov 2013

Male roundworms shorten the lifespan of females, say Stanford researchers

Researchers at the Stanford University School of Medicine have discovered that males of the laboratory roundworm secrete signaling molecules that significantly shorten the lifespan of the opposite sex.

29 Nov 2013

KKR to acquire minority stake in Gland Pharma for about $200 million

Gland Pharma Limited, a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a leading global investment firm, will acquire a minority stake in the Company for approximately US$200 million, including KKR's acquisition of the entire stake held by Evolvence India Life Sciences Fund, an existing private equity investor in Gland Pharma.

28 Nov 2013

DFG approves establishment of new Collaborative Research Centres

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of nine new Collaborative Research Centres (CRCs).

27 Nov 2013

Breakthrough discovery could lead to development of future therapeutics for prostate cancer

Drs. Andrew Goldstein, Owen Witte, and Tanya Stoyanova and their colleagues from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have found that prostate cancer can develop in one type of stem cell, then evolve to be maintained by a stem cell that looks very different, making prostate cancer stem cells a "moving target" for treatments. The breakthrough discovery connects directly to the development of future therapeutics that target cancer and was published online ahead of print in the Proceedings of the National Academy of Sciences.

27 Nov 2013

USF is among top 10 organizations worldwide with Fellows named this year

Six faculty members at the University of South Florida in Tampa have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.

26 Nov 2013

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

AATS and three cardiovascular professional societies today released an overview of transcatheter therapies for mitral regurgitation.

26 Nov 2013

SillaJen executes definitive merger agreement to acquire Jennerex

SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced today that it had executed a definitive merger agreement to acquire San Francisco-based Jennerex, Inc.

26 Nov 2013

Sacral neuromodulation stands test of time in LUTD

Follow-up of patients at a Belgian institution reveals that sacral neuromodulation is effective for the treatment of lower urinary tract dysfunction over the long term, but often requires reintervention.

From Medtronic 25 Nov 2013

CRISPR-Cas-system: A promising tool for genetic engineering

Viruses cannot only cause illnesses in humans, they also infect bacteria. Those protect themselves with a kind of 'immune system' which - simply put - consists of specific sequences in the genetic material of the bacteria and a suitable enzyme. It detects foreign DNA, which may originate from a virus, cuts it up and thus makes the invaders harmless.

25 Nov 2013

Research: Smallest parts of brain play crucial role in decision making

One of the smallest parts of the brain is getting a second look after new research suggests it plays a crucial role in decision making.

25 Nov 2013

Sorin Group receives CE Mark approval for Solo Smart stentless aortic valve

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it has received CE Mark approval for the Solo Smart stentless aortic valve.

23 Nov 2013

Study suggests that attractive or unattractive faces can make time fly or drag

The common expression 'time flies when you're having fun' suggests that people's perception of duration is moderated by the impact of their emotions and the activities they are performing; in other words, emotions such as fear or sadness affect people's perception of time. Now, a study among female students suggests that visual stimuli, such as attractive or unattractive faces, can make time fly or drag.

22 Nov 2013

Evolution News and Research

Genocea commences GEN-004 Phase 1 study to prevent pneumococcus infections

Professor receives Research Fellowship to complete biography on nutrition and heart disease researcher

UCLA researchers discover how prostate cancer stem cells evolve as the disease grows

AAAS Honors Two Tufts University faculty members as Fellows

Better understanding of cancer evolution could help in early detection of cancers

MHIF creates scientific program to address gaps in treating valvular heart disease patients

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

New methods reduce mother-to-child transmission of HIV from 23.9% to 2.4% in Gipuzkoa

Male roundworms shorten the lifespan of females, say Stanford researchers

KKR to acquire minority stake in Gland Pharma for about $200 million

DFG approves establishment of new Collaborative Research Centres

Breakthrough discovery could lead to development of future therapeutics for prostate cancer

USF is among top 10 organizations worldwide with Fellows named this year

AATS, cardiovascular professional societies release overview of transcatheter therapies for mitral regurgitation

SillaJen executes definitive merger agreement to acquire Jennerex

Sacral neuromodulation stands test of time in LUTD

CRISPR-Cas-system: A promising tool for genetic engineering

Research: Smallest parts of brain play crucial role in decision making

Sorin Group receives CE Mark approval for Solo Smart stentless aortic valve

Study suggests that attractive or unattractive faces can make time fly or drag

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News